SEC Form 4 · accession 0001209191-17-037366
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Griggs
Director
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 31, 2017 | S | 8,000 | $6.97 | D | 10,803 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to Cumberland Pharmaceuticals Inc.